Inovio Pharmaceuticals (INO)'s 30-day implied volatility (IV30) was 92.5% at the close on October 30, 2026, down from 123.1% the day before, against a 52-week range of 47.0% to 326.3%. Its 20-day historical volatility was 105.6%.
Data as of October 30, 2026.